These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8672875)

  • 1. Risk assessment of carcinogens in Japan.
    Hayashi Y
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):197. PubMed ID: 8672875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer risk assessment of direct acting carcinogens.
    Zito R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):273-8. PubMed ID: 10606168
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporating cell proliferation in quantitative cancer risk assessment: approaches, issues, and uncertainties.
    Chen C; Farland W
    Prog Clin Biol Res; 1991; 369():481-99. PubMed ID: 1946541
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental models of benzene carcinogenesis.
    Craig PH
    Prog Clin Biol Res; 1992; 374():107-22. PubMed ID: 1620700
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of human carcinogens.
    Ashby J; Morrod RS
    Nature; 1991 Jul; 352(6332):185-6. PubMed ID: 1857407
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in animal and human responses to carcinogenic metals.
    Gibb HJ; Farland WH
    Prog Clin Biol Res; 1992; 374():367-79. PubMed ID: 1620712
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinogenic risk assessment--the consequences of believing models.
    Crouch EA
    Basic Life Sci; 1983; 24():653-65. PubMed ID: 6860280
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data.
    Sielken RL; Stevenson DE
    Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708
    [No Abstract]   [Full Text] [Related]  

  • 10. A risk assessment perspective: application of mode of action and human relevance frameworks to the analysis of rodent tumor data.
    Dellarco VL; Baetcke K
    Toxicol Sci; 2005 Jul; 86(1):1-3. PubMed ID: 15939704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk evaluation of carcinogens and their threshold levels, part III].
    Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):911-20. PubMed ID: 16937321
    [No Abstract]   [Full Text] [Related]  

  • 12. Incorporating the concept of 'invaders' and 'defenders' in the dose-response modeling of carcinogens.
    Stevenson DE; Sielken RL
    Prog Clin Biol Res; 1995; 391():445-51. PubMed ID: 8532736
    [No Abstract]   [Full Text] [Related]  

  • 13. Opportunity of conservative risk assessment in carcinogenesis.
    Zapponi GA; Bucchi AR; Lupi C; Rossi L
    Med Lav; 1986; 77(4):361-9. PubMed ID: 3784943
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters.
    Perera FP
    Environ Health Perspect; 1991 Aug; 94():231-5. PubMed ID: 1954932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Brown 95.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():321-30. PubMed ID: 6957385
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct Black 38.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():295-310. PubMed ID: 6957383
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct Blue 6.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 May; 29():311-20. PubMed ID: 6957384
    [No Abstract]   [Full Text] [Related]  

  • 18. A decision tree approach for carcinogen risk assessment.
    Butterworth BE; Eldridge SR
    Prog Clin Biol Res; 1995; 391():49-70. PubMed ID: 8532737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of DNA repair in chemical carcinogenesis].
    Likhachev AIa
    Vopr Onkol; 1987; 33(1):3-11. PubMed ID: 3544490
    [No Abstract]   [Full Text] [Related]  

  • 20. New in vitro approaches to explore cellular and molecular events related to carcinogenesis.
    Fimognari C; Nüsse M; Forti GC; Hrelia P
    Pharmacol Res; 2000 Apr; 41(4):385-90. PubMed ID: 10704260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.